These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15970341)

  • 1. Effect of beta-blockers on the mortality of Japanese patients with myocardial infarction.
    Yamada K; Tsuji H; Tokunaga S; Kurimoto K; Maeba H; Matsuhisa S; Inami N; Iwasaka T
    Int J Cardiol; 2006 Apr; 108(3):309-13. PubMed ID: 15970341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Hara M; Uematsu M; Fukunami M; Hamasaki T; Sato H; Hori M; Komuro I;
    Am J Cardiol; 2013 Feb; 111(4):457-64. PubMed ID: 23228922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    Puymirat E; Riant E; Aissaoui N; Soria A; Ducrocq G; Coste P; Cottin Y; Aupetit JF; Bonnefoy E; Blanchard D; Cattan S; Steg G; Schiele F; Ferrières J; Juillière Y; Simon T; Danchin N
    BMJ; 2016 Sep; 354():i4801. PubMed ID: 27650822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?
    Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM
    Arch Intern Med; 2000 Apr; 160(7):947-52. PubMed ID: 10761959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
    Chan AY; McAlister FA; Norris CM; Johnstone D; Bakal JA; Ross DB;
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):182-7, 187.e1. PubMed ID: 20427056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discharge heart rate and mortality after acute myocardial infarction.
    Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
    Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
    Coletta C; Ricci R; Ceci V; Seccareccia F; Rulli F; Mazzuca V; Putini RL; Salustri A; Bottero G; Pasquale M
    G Ital Cardiol; 1999 Feb; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
    Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
    Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.